BioArctic AB (publ) (BRCTF)

USD 15.67

(0.0%)

Long Term Debt Summary of BioArctic AB (publ)

  • BioArctic AB (publ)'s latest annual long term debt in 2023 was 2.15 Million SEK , up 82.06% from previous year.
  • BioArctic AB (publ)'s latest quarterly long term debt in 2024 Q2 was 46.75 Million SEK , down 0.0% from previous quarter.
  • BioArctic AB (publ) reported annual long term debt of 1.18 Million SEK in 2022, down -84.82% from previous year.
  • BioArctic AB (publ) reported annual long term debt of 7.78 Million SEK in 2021, down -42.87% from previous year.
  • BioArctic AB (publ) reported quarterly long term debt of 2.38 Million SEK for 2024 Q1, down 0.0% from previous quarter.
  • BioArctic AB (publ) reported quarterly long term debt of 1.18 Million SEK for 2023 Q3, down -22.63% from previous quarter.

Annual Long Term Debt Chart of BioArctic AB (publ) (2023 - 2015)

Historical Annual Long Term Debt of BioArctic AB (publ) (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 2.15 Million SEK 82.06%
2022 1.18 Million SEK -84.82%
2021 7.78 Million SEK -42.87%
2020 13.62 Million SEK -34.88%
2019 20.92 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%

Peer Long Term Debt Comparison of BioArctic AB (publ)

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 89.708%
Evofem Biosciences, Inc. 8000.00 USD -26800.0%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -22.588%
Mesoblast Limited 100.29 Million USD 97.854%
Propanc Biopharma, Inc. 58.64 Thousand USD -3569.725%
Genus plc 228.2 Million USD 99.057%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD -222.576%
ContraFect Corporation 2.21 Million USD 2.624%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -53.393%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 60.343%
MultiCell Technologies, Inc. 36.43 USD -5907119.325%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 96.13%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 3.324%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -75.193%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 98.704%
Oncotelic Therapeutics, Inc. 1.89 Million USD -13.355%
Skye Bioscience, Inc. 171.23 Thousand USD -1156.789%
Therapeutic Solutions International, Inc. 5512.00 USD -38942.09%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 92.146%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -568.323%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.981%
Halberd Corporation 150 Thousand USD -1334.667%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD -617.333%
Nuo Therapeutics, Inc. 164.2 Thousand USD -1210.557%
argenx SE 15.35 Million USD 85.984%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 89.405%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -48194.434%
Genscript Biotech Corporation 287.12 Million USD 99.251%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -1603.853%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -838.545%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -288.034%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -8406.265%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 73.959%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -710.134%
ONE Bio Corp. 592.19 Thousand USD -263.392%
Reve Technologies, Inc. 1064.00 USD -202155.639%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1338.368%
Regen BioPharma, Inc. 149.61 Thousand USD -1338.368%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -836.911%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -1426.241%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -2590.0%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 72.481%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -483.12%
International Stem Cell Corporation 445 Thousand USD -383.596%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 73.595%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -370.897%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -85.357%
PureTech Health plc 18.25 Million USD 88.208%
Coeptis Therapeutics, Inc. 150 Thousand USD -1334.667%
IXICO plc 275 Thousand USD -682.545%
IntelGenx Technologies Corp. 11.83 Million USD 81.823%
Gelesis Holdings, Inc. 26.3 Million USD 91.82%
CSL Limited 11.23 Billion USD 99.981%
Cellectis S.A. 36.21 Million USD 94.057%